Switch to
More onapp

How to use scorecard? Learn more

Emcure Pharmaceuticals Ltd

EMCURE
Health CarePharmaceuticals
SmallcapWith a market cap of ₹24,695 cr, stock is ranked 293
Low RiskStock is 1.67x as volatile as Nifty
1,297.358.60 (-0.66%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹24,695 cr, stock is ranked 293
Low RiskStock is 1.67x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
PB RatioPB Ratio
7.91
Dividend YieldDiv. Yield
Sector PESector PE
46.01
Sector PBSector PB
6.09
Sector Div YldSctr Div Yld
0.55%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Emcure Pharmaceuticals is engaged in developing, manufacturing and marketing a range of pharmaceutical products across several therapeutic areas.

Financial TrendFinancial statements 

20212022202320245.075.926.036.720.420.660.530.50
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Press Release 
Announced OnJul 25, 2024

Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 25, 2024, titled "Emcure Pharmaceuticals strengthens its commitment to energy conservation, signs PPA with Sunsure Energy for solar power". | Download

Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 25, 2024, titled "Emcure Pharmaceuticals strengthens its commitment to energy conservation, signs PPA with Sunsure Energy for solar power". | Download

Acquisition-XBRL 
Announced OnJul 25, 2024

Emcure Pharmaceuticals Limited has informed the Exchange regarding Acquisition | Download

Emcure Pharmaceuticals Limited has informed the Exchange regarding Acquisition | Download

Acquisition 
Announced OnJul 25, 2024

Emcure Pharmaceuticals Limited has informed the Exchange about Acquisition | Download

Emcure Pharmaceuticals Limited has informed the Exchange about Acquisition | Download

See all events